Long term outcomes of pediatric Bipolar-I disorder: A prospective follow-up analysis attending to full syndomatic, subsyndromal and functional types of remission
Year: 2022
Type: article
Study design: Observational Study
Source: Journal of Psychiatric Research
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: U.S. Department of Defense, Restless Legs Syndrome Foundation, Eli Lilly and Company, Pfizer, GlaxoSmithKline, Sanofi, American Academy of Child and Adolescent Psychiatry, Patient-Centered Outcomes Research Institute, Sunovion, National Alliance for Research on Schizophrenia and Depression, Jazz Pharmaceuticals, European Commission, Shire, H. Lundbeck A/S, National Institutes of Health, Genentech, Pfizer Pharmaceuticals, American Regent, Simons Center for the Social Brain, Massachusetts Institute of Technology, National Institute of Mental Health, National Institute on Drug Abuse
Awards: Neural and Clinical Biomarkers of Risk for ADHD: A Focus on Preschoolers, 3/7 Psychiatric Genomics Consortium: Finding actionable variation, Discoveries in ADHD genomics: Help or hype in clinical settings?, Longitudinal Family Study of Pediatric Bipolar Disorder, Behavioral and Neural Response to Memantine in Adolescents with Autism
OpenAlex ID: W4225297343